FEMSelect
Treatment for Pelvic Floor Ligament Fixation
StartupFEMSelect is a Modi'in-Maccabim-Re'ut-based startup in the Health Tech & Life Sciences sector, established in 2012. Treatment for Pelvic Floor Ligament Fixation. The company has raised a total of $16.89M across 7 funding rounds, currently at the B stage. FEMSelect was founded by Boaz Harari and Prof. Menahem Neuman. Key investors include Robin Hood Ventures , New Age Ventures, RAD BioMed, among 14 total investors. The company has 11-50 employees.
With $16.89M in total funding, FEMSelect is a B-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageB
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQModi'in-Maccabim-Re'ut
- DistrictCenter District
- Last Round$540K
- Robin Hood Ventures
- New Age VenturesLead
- RAD BioMed
14 investors total
Boaz HarariCo-founder 
Prof. Menahem NeumanCo-founder & Medical Director
7 articles covered by sources including www.calcalistech.com,
www.finsmes.com,
www.prnewswire.com,
www.massdevice.com,
globenewswire.com.
What does FEMSelect do?
FEMSelect is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. The EnPlace procedure takes approximately 30 minutes. Its patented delivery system enables precise guidance, insertion, and deployment of the anchor unit, which is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. EnPlace is FDA cleared and CE marked. The device is a combination of a Nitinol-based anchor, surgical sutures, and an innovative attachment method, and the surgery is conducted with no deep dissection or mesh. EnPlace has been tested in a human trial in Israel and is protected by global and U.S. patents.
How much funding has FEMSelect raised?
FEMSelect has raised $16.89M in total funding across 7 rounds. The company is currently at the B stage. Key investors include Robin Hood Ventures , New Age Ventures, RAD BioMed.
Who founded FEMSelect?
FEMSelect was founded in 2012 by Boaz Harari (Co-founder ), Prof. Menahem Neuman (Co-founder & Medical Director).
What sector is FEMSelect in?
FEMSelect operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Consumers, Demographics & Family, Women, Healthcare & Life Sciences, Healthcare, Providers.
Where is FEMSelect located?
FEMSelect is based in HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel, Center District. The company also has offices abroad.